Skip to content

Study · Measured the body's own peptide · 1996

1 result

Regulation of prothymosin alpha during the cell cycle.

Vareli K, Tsolas O, Frangou-Lazaridis M

European journal of biochemistry1 Jun 1996Cited by 27 (Europe PMC)

PMID8706683 (opens in a new tab)DOI10.1111/j.1432-1033.1996.0799w.x (opens in a new tab)PepBankPUB-08706683
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Other

    In mononuclear and fibroblastic cells, the immunoreactive material was prothymosin alpha rather than the amino-terminal peptide thymosin alpha‑1.

    In plain wordsIn lab tests on cells, the material found was prothymosin alpha, not the body's own thymosin alpha‑1.

    Peptide
    Thymosin alpha-1
    Outcome
    Not applicableIdentity of immunoreactive material in cells
    Study

    n: not reported in source

    mononuclear cells and fibroblastic cells
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    We reported here that the material present in the cells is prothymosin alpha rather than the amino-terminal peptide thymosin alpha 1.
    1 context sentence
    Summary · context
    To investigate the regulation of prothymosin alpha, we examined its mRNA and protein levels during the cell cycle of mononuclear cells and fibroblastic cells.

    This result measures the body's own Thymosin alpha-1. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.